CJC-1295 (No DAC) + Ipamorelin 5 mg + 5 mg

Overview

CJC-1295 (No DAC) + Ipamorelin combines two well-characterized research peptides in a single 5 mg + 5 mg lyophilized formulation intended exclusively for laboratory research.

CJC-1295 (No DAC) is a synthetic analogue of growth hormone-releasing hormone (GHRH), while Ipamorelin is a selective growth hormone secretagogue that has been widely investigated for its interaction with the ghrelin receptor (GHSR-1a). Together, these compounds are frequently studied in laboratory settings to investigate growth hormone signaling, endocrine physiology, and peptide interactions.

NextCell Peptides supplies Research Grade CJC-1295 (No DAC) + Ipamorelin 5 mg + 5 mg as a high-purity lyophilized peptide blend manufactured under controlled quality standards. Each vial is clearly labeled to support product identification and laboratory traceability.

Product Specifications

Product

CJC-1295 (No DAC) + Ipamorelin

Quantity

5 mg + 5 mg

Appearance

White to off-white lyophilized powder

Purity

≥99% (HPLC)

Grade

Research Grade

What Is CJC-1295 (No DAC) + Ipamorelin?

CJC-1295 (No DAC) is a synthetic peptide derived from growth hormone-releasing hormone (GHRH). Unlike the DAC-modified version, CJC-1295 (No DAC) does not contain a Drug Affinity Complex (DAC), resulting in different pharmacokinetic characteristics that are commonly investigated in laboratory research.

Ipamorelin is a synthetic pentapeptide that has been widely studied as a selective agonist of the growth hormone secretagogue receptor (GHSR-1a). Because of its receptor selectivity, it has become a frequently investigated research peptide in endocrine and molecular biology studies.

The combination of these two peptides is commonly explored in experimental research to better understand hormone signaling pathways, receptor interactions, and peptide pharmacology.

Common Laboratory Applications

CJC-1295 (No DAC) + Ipamorelin is frequently investigated in laboratory research involving:

• Growth hormone signaling

• Endocrine physiology

• GHRH receptor biology

• Ghrelin receptor (GHSR-1a) research

• Peptide pharmacology

• Molecular biology

• Cell signaling pathways

• Experimental peptide interactions

• Hormone regulation research

• Laboratory peptide studies

The specific application depends on the laboratory protocol and experimental objectives.

Why This Peptide Combination Is Studied

CJC-1295 (No DAC) and Ipamorelin are often investigated together because they act through different biological signaling pathways that are relevant to growth hormone regulation.

Their distinct mechanisms have made this peptide combination a common subject of laboratory research exploring receptor biology, endocrine signaling, and peptide interactions under controlled experimental conditions.

Storage & Handling

Store refrigerated at 2–8°C.

For extended storage, keep frozen at −20°C.

Protect from moisture, excessive heat, and direct light.

After reconstitution, handle using appropriate laboratory procedures and avoid repeated freeze–thaw cycles whenever possible to help maintain sample integrity.

Choosing Research Grade CJC-1295 (No DAC) + Ipamorelin

When evaluating research peptides, consider factors beyond the reported purity.

Important considerations include:

• HPLC purity testing

• Batch consistency

• Product labeling

• Certificate of Analysis (COA) availability

• Manufacturing standards

• Appropriate storage recommendations

• Packaging integrity

These factors help support reliable laboratory workflows and reproducible research.

Frequently Asked Questions

What is CJC-1295 (No DAC)?

CJC-1295 (No DAC) is a synthetic analogue of growth hormone-releasing hormone (GHRH) that does not contain a Drug Affinity Complex (DAC). It is widely investigated in laboratory research involving endocrine physiology and peptide signaling.

What is Ipamorelin?

Ipamorelin is a synthetic pentapeptide studied as a selective agonist of the growth hormone secretagogue receptor (GHSR-1a). It is commonly used in laboratory research exploring receptor biology and peptide interactions.

Why are CJC-1295 (No DAC) and Ipamorelin combined?

Researchers frequently investigate this combination because the two peptides interact with different signaling pathways involved in growth hormone regulation, making them useful for studies of endocrine physiology and peptide pharmacology.

How should this product be stored?

Store the lyophilized peptide blend at 2–8°C. For extended storage, freezing at −20°C is recommended. Protect the product from moisture, excessive heat, and direct light.

Is a Certificate of Analysis (COA) available?

Yes. Batch-specific Certificates of Analysis (COAs) are available to support product verification and laboratory documentation.

Research Use Only

This product is supplied exclusively for laboratory research and analytical purposes.

It is not intended for human consumption, veterinary use, therapeutic applications, diagnostic procedures, or use as a pharmaceutical product.